Results 1 to 10 of about 12,327 (198)

Risk factors for recurrent vulvovaginal candidiasis [PDF]

Vojnosanitetski Pregled, 2010
Background/Aim. Recurrent vulvovaginal candidiasis is relatively frequent condition, and may have serious health consequences, like chronic vulvovaginal pain syndrome. The aim of our study was to determine possible risk factors for recurrent vulvovaginal
Janković Slobodan, Bojović Dragica, Vukadinović Dubravka, Daglar Elmedina, Janković Marija, Laudanović Dragomir, Lukić Vladan, Mišković Vesna, Potpara Zorica, Projović Ivana, Čokanović Vesna, Petrović Nadežda, Folić Marko, Savić Viktorija   +13 more
doaj   +3 more sources

Fluconazole-resistant vulvovaginal candidiasis in reproductive-age women: a study from Himalayan country [PDF]

BMC Microbiology
Background Vulvovaginal candidiasis is the second most common fungal infections among reproductive-age women. These conditions are commonly treated with the azole derivatives administered locally or systemically, most commonly fluconazole (FCZ).
Deepshikha Yadav, Purnima Baidya, Prabhakar R. Panday, Pritee Yadav, Kul R. Rai, Prasha Shrestha, Manita Aryal   +6 more
doaj   +2 more sources

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis

Frontiers in Immunology, 2022
Recurrent vulvovaginal candidiasis (RVVC) and vulvovaginal candidiasis (RVVC) are one of the most common gynecological infections, primarily caused by Candida species. Although risk factors of RVVC and VVC have been identified in many studies, antifungal
Gai Ge, Zhiya Yang, Dongmei Li, Ning Zhang, Biao Chen, Dongmei Shi, Dongmei Shi   +6 more
doaj   +3 more sources

Recurrent vulvovaginal candidiasis associated with the use of a probiotic supplement [PDF]

IDCases
Background: Recurrent vulvovaginal candidiasis (RVVC) is a common cause of morbidity in women with vulvovaginal complaints. Saccharomyces species have been shown to cause vulvovaginal candidiasis in only 2 % - 6 % of RVVC cases. However, these infections
Chemen M. Neal, Andrea I. Gonzalez, Adeoti Oshinowo, Trilliah Fazle, Tavonna Kako   +4 more
doaj   +2 more sources

Vulvovaginal Candidiasis [PDF]

Pharmacy Today, 2019
Vulvovaginal candidiasis is the second most common vaginal infection after bacterial vaginosis. It is caused by yeasts, the vast majority of which belong to the genus Candida. Vulvovaginal candidiasis affects as many as 75 % of women during their childbearing years and 40 % of them experience recurrences.
Jill C. Cash, Rhonda Arthur
  +5 more sources

Vulvovaginal candidiasis

Obstetrics and Gynecology Clinics of North America, 2003
VVC represents a spectrum of disease. Although there is a clear need for better use of diagnostic modalities and development of better treatment alternatives, most patients with VVC, even the complicated cases, at least have the perspective of achieving adequate control of their symptoms.
Paul, Nyirjesy, Jack D, Sobel
  +9 more sources

Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis

SAGE Open Medicine, 2022
Vulvovaginal candidiasis is a common infection associated most often with the overgrowth of the fungal species Candida albicans . Although most women will have at least one episode of vulvovaginal candidiasis in their lifetime, some will experience ...
Chemen M Neal, Mark G Martens
doaj   +1 more source

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp

Journal of Investigative Medicine High Impact Case Reports, 2022
Recurrent vulvovaginal candidiasis is a common disorder which causes significant morbidity among women worldwide, and treatment options are limited.
Leah M. Grant MD, Robert Orenstein DO
doaj   +1 more source

Increased vulvovaginal candidiasis incidence risk in various gestational ages at a private midwifery practice in Surabaya, Indonesia

Majalah Obstetri dan Ginekologi, 2022
HIGHLIGHTS 1. Hormonal changes during pregnancy lead to the presence of vulvovaginal candidiasis. 2. Increased incidence of vulvovaginal candidiasis in different pregnancy trimesters were analyzed. 3.
Regina Martina Cilik, Willy Sandhika, Zakiyatul Faizah   +2 more
doaj   +1 more source

Vaginal yeasts in the era of "over the counter" antifungals [PDF]

, 2000
OBJECTIVE: To establish whether there has been any rise in the prevalence of non-albicans Candida species isolated from vaginal swabs since the introduction of “over the counter” antifungal treatments.
Ashbee, H.R., Brown, C., Evans, E.G.V., Reynolds, M.T., Walker, P.P.   +4 more
core   +8 more sources